Growing diagnostics ARBO R ASSAYS is expanding its DetectX ELISA kit catalog with biomarkers like TXB2 and BNP, indicating a growing product line in cardiovascular and inflammatory assays that can be cross-sold to researchers needing multiplex biomarker panels.

Animal model focus Recent launches include mouse TNF-alpha ELISA kits, highlighting opportunities to target preclinical and translational researchers working with murine models who require species-specific assays.

Strategic partnerships Past collaborations with ISWE and ongoing wildlife endocrinology work suggest openings to co-sell or co-develop assays for wildlife and conservation science, broadening reach to academia and non-profit labs.

Owner-Driven stability As an employee-owned, quality- and service-focused company, Arbor Assays can be positioned as a reliable vendor with strong post-sale support, ideal for customers seeking long-term supplier partnerships.

Mid-market positioning With revenue in the 10–25 million range and a lean team, there is potential to upsell premium assays, automation-friendly kits, and scalable ELISA solutions to similar mid-sized labs seeking cost-effective, high-quality tools.